Abstract
A key requirement in studies of endemic vector-borne or zoonotic disease is an estimate of the spatial variation in vector or reservoir host abundance. For many vector species, multiple indices of abundance are available, but current approaches to choosing between or combining these indices do not fully exploit the potential inferential benefits that might accrue from modelling their joint spatial distribution. Here, we develop a class of multivariate generalized linear geostatistical models for multiple indices of abundance. We illustrate this novel methodology with a case study on Norway rats in a low-income urban Brazilian community, where rat abundance is a likely risk-factor for human leptospirosis. We combine three indices of rat abundance to draw predictive inferences on a spatially continuous latent process, rattiness, that acts as a proxy for abundance. We show how to explore the association between rattiness and spatially varying environmental factors, evaluate the relative importance of each of the three contributing indices, assess the presence of residual, unexplained spatial variation, and identify rattiness hotspots. The proposed methodology is applicable more generally as a tool for understanding the role of vector or reservoir host abundance in predicting spatial variation in the risk of human disease.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funding for this project was received from: the Minist é rio da Ciência, Tecnologia e Inovaçâo, Brazil through the Conselho Nacional de Desenvolvimento Científico e Tecnológico and Fundaçâo de Amparo à Pesquisa do Estado da Bahia, Secretaria Municipal de Saúde de Salvador-BA, Fundaçâo Oswaldo Cruz (grant 10206/20155), Medical Research Council, UK (grants 1964635, MR/P024084/1, MR/T029781/1), the Ministério da Saúde, Brazil, the National Institute of Allergy and Infectious Diseases, USA (grants F31 AI114245, R01 AI052473, R01 TW009504, R25 TW009338, U01 AI088752) and the Wellcome Trust (grants 102330/Z/13/Z, 218987/Z/19/Z).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The ethics committee for the use of animals from the Oswaldo Cruz Foundation, Salvador, Brazil approved the protocols used in this study (protocol number 003/2012), which adhered to the guidelines of the American Society of Mammalogists for the use of wild mammals in research (Sikes and Gannon, 2011) and the guidelines of the American Veterinary Medical Association for the euthanasia of animals (Leary et al., 2013). These protocols were also approved by the Yale University Institutional Animal Care and Use Committee (IACUC), New Haven, Connecticut (protocol number 2012-11498). Sikes RS, Gannon WL, Animal Care and Use Committee of the American Society of Mammalogists. Guidelines of the American Society of Mammalogists for the use of wild mammals in research. J Mammal. 2011; 92:235-253. Leary S, Underwood W, Lilly E, Anthony R, Cartner S, Corey D, et al. AVMA guidelines for the euthanasia of animals: 2013 Edition. Schaumburg, Illinois: American Veterinary Medical Association; 2013.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
R scripts for the rattiness model and all data needed for our analysis are available at https://github.com/maxeyre/Rattiness-1.
